Amphastar Pharmaceuticals Inc
AMPH
Get informed when a big investor buys or sells
+ FollowMarket Cap$831.15M
Close$
$39.20
109.6% upside
Current Fair Value
109.6% upsideUndervalued by 109.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $831.15 Million |
|---|---|
| Enterprise Value | $746.39 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.1 |
| Beta | 0.97 |
| Outstanding Shares | 45,322,000 |
Return
| Return on Equity | 10.24% |
|---|---|
| Return on Assets | 4.81% |
| Return on Invested Capital | 8.30% |
Valuation & Multiples
| P/E Ratio | 10.78 |
|---|---|
| PEG | -14.45 |
| Price to Sales | 1.25 |
| Price to Book Ratio | 1.1 |
| Enterprise Value to Revenue | 1.04 |
| Enterprise Value to EBIT | 6.06 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$0.72
Average shareholder expectationRevenue Estimate
$174.09 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.67
Average shareholder expectationRevenue Estimate
$180.34 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 80,900▲ 217.25% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 68.63%▼ 3.62% |
|---|---|
| Total Invested | $628.84M▼ 30.10% |
| Investors Holding | 214▼ 23.00% |
ESG Score
No data
About Amphastar Pharmaceuticals Inc
CEO: Jack Zhang